Express Scripts Stock Rises On Rosy 2013 Guidance
Shares of drug-benefits management giant Express Scripts (ESRX) jumped 2.6% in mid-day trading after the company gave better than expected earnings guidance for 2013. Management said it expected adjusted earnings of $4.20 to $4.30 a share, or 12% to 15% higher than in 2012. Wall Street's consensus was $4.20, according to Thomson Reuters. It was revised downward in early November after management said in Q3 commentary that estimates were too high
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here